Critical Reviews™ in Therapeutic Drug Carrier Systems
Publicou 6 edições por ano
ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X
IF:
2.7
5-Year IF:
3.6
Immediacy Index:
0.8
Eigenfactor:
0.00023
JCI:
0.39
SJR:
0.42
SNIP:
0.89
CiteScore™::
5.5
H-Index:
79
Indexed in
Volume 29, 2012 Edição 2
DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i2
Critical Aspects in Rationale Design of Fluorouracil-Based Adjuvant Therapies for the Management of Colon Cancer
pp. 89-148
DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i2.10
Drug-Loaded PLGA Nanoparticles for Oral Administration: Fundamental Issues and Challenges Ahead
pp. 149-182
DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i2.20